Gerard Sheridan has 25 years of international operating and consulting experience with
extensive knowledge of US and European markets with Roche
Pharmaceuticals and Medtronic (CFO for French and Dutch
manufacturing and distribution activities)
Served as CFO at Molecular Health in the precision medicine space
and CFO at Seno Medical Instruments, Inc., where he worked to raise
over $100M in capital.
Initiated his career with PricewaterhouseCoopers in the audit and transaction advisory practices serving a variety of clients across a broad spectrum of sectors.
The San Antonio Business Journal named him 2011 Best CFO.
Gerry graduated from University College Dublin in Ireland and is a qualified Chartered Accountant, as well as being certified with a Diplôme d'Expertise-Comptable (DEC) in France and a Certified Public Accountant, licensed in the State of Texas and is a member of the American Institute of Certified Public Accountants.